Treatment with Cellgevity® improves glycemic index and prevents atherogenic dyslipidemia in Type 2 Diabetic rat model. JHS [Internet]. 2025 Aug. 3 [cited 2026 May 12];3(1):24-31. Available from: https://lasujournals.ng/index.php/jhs/article/view/75